Blood cell ratios may predict asthma flare risk

NCT ID NCT07730047

Not yet recruiting Knowledge-focused Sponsor: Shaimaa Ali Mohammed Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study is testing whether three simple blood test measurements — the neutrophil-to-lymphocyte ratio (NLR), eosinophil-to-lymphocyte ratio (ELR), and systemic immune-inflammation index (SII) — can help assess how well asthma is controlled in adults. Researchers will compare these blood markers with the standard Asthma Control Test (ACT) score in 140 adults with bronchial asthma. If the markers correlate well, they could become a quick, inexpensive tool for doctors to monitor asthma control during routine checkups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If these blood test ratios prove reliable, they could offer a simple, low-cost way to monitor asthma control in clinics.
What could go wrong: This is an observational study, not a treatment trial. The biomarkers may not be accurate enough to replace current assessment methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA CONTROL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA CONTROL

Contacts and locations

Locations

Chest Department,Assiut University Hospital

Asyut, Asyut Governorate, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.